Final Release. The release of the API by NGX QA Unit for further processing of finished product for clinical trials or commercial use. Final release signifies that the material has been produced using approved processes and meets the established specifications and regulatory submissions as determined by NGX QA review of all relevant documentation.
Appears in 2 contracts
Sources: Manufacturing Agreement, Manufacturing and Supply Agreement (NeurogesX Inc)